Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study

Gilles Battesti, Charline Garcia,Manuelle Viguier, Valentine Marchal,Marion Castel,Pascal Joly,Anne-Pham Ledard,Maria-Polina Konstantinou,Vannina Seta,Nadège Cordel,Sophie Duvert-Lehembre,Emmanuelle Tancrède-Bohin,Thibaut Belmondo,Saskia Ingen-Housz-Oro,Michel d'Incan

Journal of the American Academy of Dermatology（2022）

引用 1|浏览7

暂无评分

摘要

In real-life practice, in bullous pemphigoid, the 3- and 6-month relapse rates were not significantly reduced with TC decision based on results of ITs as compared with a classic clinical-based decision.

查看译文

关键词

anti-BP180,bullous pemphigoid,DIF,ELISA,relapse,treatment cessation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要